About this episode

As the world commits to equitable access to medicines and vaccines, is this just on paper or a reality?  In the case of COVID-19, as of early March 2022, 74% of those in high-income countries have been fully vaccinated, compared with just 11% of people in low-income countries. Can South Africa’s experience with tackling HIV/AIDS and COVID-19 point to future solutions for other low- and middle-income countries? How has intellectual property rights affected development of vaccines across Africa? 

You may also be interested in these previous episodes

The CC BY-NC-SA 3.0 IGO creative commons license allows users to freely copy, reproduce, reprint, distribute, translate and adapt the work for non-commercial purposes, provided TDR is acknowledged as the source and adapted material is issued under the same licensing terms using the following suggested citation: Global Health Matters. Geneva: TDR; 2021. License: CC BY-NC-SA 3.0 IGO.